Intentar ORO - Gratis
Driving Research Continuity in Indian R&D through Remote Lab Operations
Bio Spectrum
|September 2025
India's research landscape is undergoing rapid transformation as institutions look toward hybrid and remote working models to enhance flexibility and collaboration. By turning to cloudbased lab systems and AI-powered analytics, R&D organisations can build agile, future-ready environments to help power India's academic and industrial sectors.
-

Dr Mary Donlan, Executive Director, Product Marketing, Revvity Signals
The COVID-19 pandemic marked a turning point for research and development practices throughout the world. With restricted access to physical laboratories due to nationwide lockdowns, traditional on-site research models were disrupted overnight. In response, R&D organisations were compelled to adopt hybrid and remote research models, combining in-person lab work with digital off-site data analysis.
Ignited by the short-term necessity of COVID-19, digital R&D solutions have now evolved to redefine remote research frameworks and transform how research continuity is maintained. Moving from manual processes largely confined within the four walls of the lab to data-driven research that is independent of location, institutions have learned that the data itself represents the greatest store of value. As a result, reliable, flexible, secure access to lab-generated data is at a premium, and remote and cloud solutions have surged to fill a market gap.
For example, in a survey conducted soon after the start of the pandemic, Deloitte showed that drug companies rated cloud computing as one of the highest priorities of the following 5 years.
In the work-from-anywhere hybrid environment, it is no longer practical for data to be encased within physical lab notebooks or local data systems.
Researchers working from different locations require safe, real-time access, analysis and sharing of protocols and experimental results to maintain momentum in their projects and promote collaboration across departments and institutions.
In this new environment, cloud-based Electronic Lab Notebooks (ELNs) with AI-powered data analytic platforms play a key role. These solutions enable remote data accessibility, enhanced data integrity, and compliance with regulatory standards – crucial factors in both academic research and industrial R&D.
Esta historia es de la edición September 2025 de Bio Spectrum.
Suscríbete a Magzter GOLD para acceder a miles de historias premium seleccionadas y a más de 9000 revistas y periódicos.
¿Ya eres suscriptor? Iniciar sesión
MÁS HISTORIAS DE Bio Spectrum

Bio Spectrum
Navigating the Complexities of Pharma Packaging Sustainability
Pharma companies in India are increasingly adopting sustainable methods in packaging to ensure that medicines remain safe and the environment is protected. Various initiatives by the government, focusing on reducing carbon footprints, are revolutionising the pharma packaging industry.
8 mins
September 2025

Bio Spectrum
Are BioStartUps in a Funding/Innovation Rut?
At the BioStartUps Founders & Investors Forum 2025, held on August 1, 2025 at the CIDCO Exhibition Centre in Vashi, Navi Mumbai, biotech industry stalwarts deliberated on the country's innovation and startup ecosystem.
10 mins
September 2025

Bio Spectrum
How Do Recent Deaths Impact Gene Therapy Development?
Cell and gene therapy (CGT) is among the most closely watched areas in pharma and biotech.
4 mins
September 2025

Bio Spectrum
HealthQuad appoints Namit Chugh as Director
Quadria Group, Asia's leading healthcare-focused private equity platform, has announced the appointment of Namit Chugh as Director at HealthQuad, India's leading healthcare-focused growth venture capital platform.
1 min
September 2025

Bio Spectrum
Why Is Endoscopy Crucial for Gl Cancer Diagnosis?
The increased demand for gastrointestinal (GI) diagnostics in India, driven by rising disease rates and awareness of early intervention, is not evenly distributed. While major urban hospitals have expanded their endoscopic capabilities, many semi-urban and rural areas face limited access. Addressing this disparity is crucial for extending the benefits of early disease detection across the country.
4 mins
September 2025
Bio Spectrum
New England Biolabs launches NEBNext low-bias small RNA library prep kit
US-based New England Biolabs (NEB) has announced the launch of the NEBNext Low-bias Small RNA Library Prep Kit, designed to minimise biased representation of small RNA species in sequencing data.
1 min
September 2025

Bio Spectrum
Qiagen expands NGS portfolio with launch of QIAseq XHYB long read panels
Qiagen has announced the launch of its new QIAseq xHYB Long Read Panels, a suite of target enrichment solutions designed to unlock long-read sequencing of genomically complex regions.
1 min
September 2025

Bio Spectrum
"Awareness and consistent training are needed with the growing demand for effective skin treatments in India"
India’s dermatology and aesthetic market is reportedly among the fastest-growing globally, projected to grow at a CAGR of 10.11 per cent from 2025 to 2032.
4 mins
September 2025
Bio Spectrum
Dr. Moopen's Legacy Scholarship & Fellowships to aid 25 students from across India
In a path breaking initiative to make medical education accessible to meritorious students and students from economically challenged backgrounds, Padma Shri Dr Azad Moopen, Founder & Chairman of Aster DM Healthcare and a globally recognised philanthropist, has announced an annual scholarship programme Dr. Moopen's Legacy Scholarship & Fellowships Programme aimed at supporting meritorious students seeking admissions in Dr. Moopen's Medical College, Dr Moopen's Nursing College and Dr Moopen's College of Pharmacy in Wayanad, Kerala.
1 min
September 2025

Bio Spectrum
Iberia Pharma set to open manufacturing unit in India with investment of Rs 70 Cr
Gurugram-based Iberia Pharmaceuticals has announced its new hi-tech manufacturing and research facility spread across 60,000 sq. ft. in Jhajjar, Haryana.
1 min
September 2025
Listen
Translate
Change font size